R 0005/15 (Right to be heard II/EURO-CELTIQUE) of 29.5.2017

European Case Law Identifier: ECLI:EP:BA:2017:R000515.20170529
Date of decision: 29 May 2017
Case number: R 0005/15
Petition for review of: T 1938/09
Application number: 98906678.2
IPC class: A61F 13/00
A61K 31/485
A61K 9/70
Language of proceedings: EN
Distribution: B
Download and more information:
Decision text in EN (PDF, 62 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Sustained analgesia achieved with transdermal delivery of buprenorphine
Applicant name: EURO-CELTIQUE S.A.
Opponent name: Hexal AG
Luye Pharma AG
Board: EBA
Headnote: -
Relevant legal provisions:
European Patent Convention Art 112a(2)(c)
European Patent Convention Art 112a(2)(d)
European Patent Convention Art 113(1)
European Patent Convention R 104(b)
European Patent Convention R 106
Keywords: Right to be heard – fundamental violation (no)
Omission to decide on a relevant request (no)
Other fundamental procedural defect (no)
Catchwords:

-

Cited decisions:
G 0009/91
R 0001/08
R 0010/09
R 0012/09
R 0016/09
R 0013/12
R 0001/13
R 0002/14
R 0013/14
T 2362/08
Citing decisions:
-

20 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

EPC Implementing Rules

Case Law Book: III Amendments

Case Law Book: V Priority

Case Law of the Enlarged Board

General Case Law